Prior to the March 2016 FDA approval of a game-changing piece of vascular stent technology, a patient with a large iliac artery aneurysm would have been cut open from their sternum to the pelvis, ...

Vascular diseases are one of the most common causes of death around the globe. Encompassing a range of conditions (such as atherosclerosis, pulmonary embolism, and deep vein thrombosis), vascular ...

Xcellerex will leverage its XDR bioreactors and FlexFactory platform to allow future scale-up. Xcellerex and Humacyte signed a collaboration agreement under which Xcellerex will develop a single-use ...

Velano Vascular today announced that the U.S. Food and Drug Administration (FDA) has granted marketing clearance for a new technology that provides an innovative approach to one of the most common ...

BD (Becton, Dickinson and Co.) announced on July 20 that through its recent acquisition of Velano Vascular it has taken a step forward in transforming the patient experience through a vision of a “One ...

Blood vessel replacements (vascular grafts) are used today for hemodialysis blood access, trauma repair and cardiovascular reconstruction The first synthetic vascular grafts (blood vessel replacements ...

In a study published in the journal Burns & Trauma, researchers from Shanghai Jiao Tong University and Donghua University developed a new type of vascular graft using 3D printing and electrospinning.

Do you know what the back of your hand says about you? Or your finger or palm for that matter? Quite a bit … if you are looking beyond the surface to track the pattern of veins that can uniquely ...

SAN JOSE, Calif., March 25, 2025--(BUSINESS WIRE)--Evident Vascular, Inc., a medical technology company developing a best-in-class intravascular ultrasound (IVUS) platform powered by artificial ...

WEST LAFAYETTE, Ind. – Purdue University researchers have developed an analytical imaging technology based on functional MRI for detecting and monitoring cerebral vascular disorders and injuries that ...

Novel embolic device designed to obstruct or reduce blood flow, Funded by Strategic Investor. DENVER, Oct. 24, 2025 /PRNewswire/ -- Polyembo, a privately held medical device company founded to develop ...